Drug ID: | NPD7314 |
Drug Name: | |
Molecular Formula: | C29H41NO6 |
Canonical SMILES: | CO[C@@H]1[C@@H](CC[C@@]2([C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)CO2)OC(=O)/C=C/c1ccc(cc1)OCCN(C)C |
Standard InCHI: | InChI=1S/C29H41NO6/c1-20(2)7-13-24-28(3,36-24)27-26(32-6)23(15-16-29(27)19-34-29)35-25(31)14-10-21-8-11-22(12-9-21)33-18-17-30(4)5/h7-12,14,23-24,26-27H,13,15-19H2,1-6H3/b14-10+/t23-,24-,26-,27-,28+,29+/m1/s1 |
Standard InCHIKey: | ZEZFKUBILQRZCK-MJSCXXSSSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB013122; DCL001259; DIB008669 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 6918502; 25144864 |
ChEBI | |
CAS Number |
Molecular Weight | 499.29 |
ALogP | 1.2003 |
MLogP | 3.88 |
XLogP | 4.493 |
HDA | 6 |
HBD | 0 |
Rotatable Bonds | 18 |
TPSA | 73.06 |
RO5 Violation | 1 |